LOINC_NUM
stringlengths
3
8
COMPONENT
stringlengths
2
246
PROPERTY
stringlengths
1
29
TIME_ASPCT
stringlengths
1
15
SYSTEM
stringlengths
1
106
SCALE_TYP
stringclasses
10 values
METHOD_TYP
stringlengths
1
57
CLASS
stringlengths
2
24
CLASSTYPE
int64
1
4
LONG_COMMON_NAME
stringlengths
3
254
SHORTNAME
stringlengths
2
51
EXTERNAL_COPYRIGHT_NOTICE
stringlengths
39
2.6k
STATUS
stringclasses
4 values
VersionFirstReleased
stringlengths
1
7
VersionLastChanged
stringlengths
1
5
100002-5
Specimen care is maintained
Find
Pt
^Patient
Ord
null
SURVEY.PNDS
4
Specimen care is maintained
null
null
ACTIVE
2.72
2.72
100003-3
Team communication is maintained throughout care
Find
Pt
^Patient
Ord
null
SURVEY.PNDS
4
Team communication is maintained throughout care
null
null
ACTIVE
2.72
2.72
100004-1
Demonstrates knowledge of the expected psychosocial responses to the procedure
Find
Pt
^Patient
Ord
null
SURVEY.PNDS
4
Demonstrates knowledge of the expected psychosocial responses to the procedure
null
null
ACTIVE
2.72
2.72
100005-8
Demonstrates knowledge of nutritional management related to the procedure
Find
Pt
^Patient
Ord
null
SURVEY.PNDS
4
Demonstrates knowledge of nutritional management related to the procedure
null
null
ACTIVE
2.72
2.72
100006-6
Demonstrates knowledge of medication management
Find
Pt
^Patient
Ord
null
SURVEY.PNDS
4
Demonstrates knowledge of medication management
null
null
ACTIVE
2.72
2.72
100007-4
Demonstrates knowledge of pain management
Find
Pt
^Patient
Ord
null
SURVEY.PNDS
4
Demonstrates knowledge of pain management
null
null
ACTIVE
2.72
2.72
10000-8
R wave duration.lead AVR
Time
Pt
Heart
Qn
EKG
EKG.MEAS
2
R wave duration in lead AVR
R wave dur L-AVR
null
ACTIVE
1.0i
2.48
100008-2
Demonstrates knowledge of wound management
Find
Pt
^Patient
Ord
null
SURVEY.PNDS
4
Demonstrates knowledge of wound management
null
null
ACTIVE
2.72
2.72
100009-0
Demonstrates knowledge of the procedure and expected results
Find
Pt
^Patient
Ord
null
SURVEY.PNDS
4
Demonstrates knowledge of the procedure and expected results
null
null
ACTIVE
2.72
2.72
100010-8
No injury related to procedure equipment, medical supplies, or instrumentation
Find
Pt
^Patient
Ord
null
SURVEY.PNDS
4
No injury related to procedure equipment, medical supplies, or instrumentation
null
null
ACTIVE
2.72
2.72
100011-6
No injury related to an electrical source
Find
Pt
^Patient
Ord
null
SURVEY.PNDS
4
No injury related to an electrical source
null
null
ACTIVE
2.72
2.72
100012-4
Participates in decisions affecting the patient's plan of care
Find
Pt
^Patient
Ord
null
SURVEY.PNDS
4
Participates in decisions affecting the patient's plan of care
null
null
ACTIVE
2.72
2.72
100013-2
Participates in the discharge process
Find
Pt
^Patient
Ord
null
SURVEY.PNDS
4
Participates in the discharge process
null
null
ACTIVE
2.72
2.72
100014-0
Psychosocial health is maintained at or improved from baseline
Find
Pt
^Patient
Ord
null
SURVEY.PNDS
4
Psychosocial health is maintained at or improved from baseline
null
null
ACTIVE
2.72
2.72
100015-7
No injury related to positioning due to care or procedure
Find
Pt
^Patient
Ord
null
SURVEY.PNDS
4
No injury related to positioning due to care or procedure
null
null
ACTIVE
2.72
2.72
10001-6
R wave duration.lead I
Time
Pt
Heart
Qn
EKG
EKG.MEAS
2
R wave duration in lead I
R wave dur L-I
null
ACTIVE
1.0i
2.48
100016-5
No injury related to a laser source
Find
Pt
^Patient
Ord
null
SURVEY.PNDS
4
No injury related to a laser source
null
null
ACTIVE
2.72
2.72
100017-3
Perioperative nursing data set outcomes panel
-
Pt
^Patient
-
PNDS
PANEL.SURVEY.PNDS
4
Perioperative nursing data set outcomes panel [PNDS]
null
©AORN Syntegrity, Inc. Used with permission.Commercial or facility use requires a license from AORN Syntegrity or an authorized reseller.
ACTIVE
2.72
2.72
100018-1
Note
Find
Pt
{Setting}
Doc
Hospice care
DOC.ONTOLOGY
2
Hospice care Note
Hospice care Note
null
ACTIVE
2.72
2.72
100019-9
ALK gene targeted mutation analysis
Prid
Pt
Bld/Tiss
Nom
Molgen
MOLPATH.MUT
1
ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
ALK gene Mut Anl Bld/T
null
ACTIVE
2.72
2.72
100020-7
GNA11 gene targeted mutation analysis
Prid
Pt
Bld/Tiss
Nom
Molgen
MOLPATH.MUT
1
GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
GNA11 gene Mut Anl Bld/T
null
ACTIVE
2.72
2.72
100021-5
GNAQ gene targeted mutation analysis
Prid
Pt
Bld/Tiss
Nom
Molgen
MOLPATH.MUT
1
GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
GNAQ gene Mut Anl Bld/T
null
ACTIVE
2.72
2.72
100022-3
IDH1 gene targeted mutation analysis
Prid
Pt
Bld/Tiss
Nom
Molgen
MOLPATH.MUT
1
IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
IDH1 gene Mut Anl Bld/T
null
ACTIVE
2.72
2.72
100023-1
IDH2 gene targeted mutation analysis
Prid
Pt
Bld/Tiss
Nom
Molgen
MOLPATH.MUT
1
IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
IDH2 gene Mut Anl Bld/T
null
ACTIVE
2.72
2.72
10002-4
R wave duration.lead II
Time
Pt
Heart
Qn
EKG
EKG.MEAS
2
R wave duration in lead II
R wave dur L-II
null
ACTIVE
1.0i
2.48
100024-9
SETBP1 gene targeted mutation analysis
Prid
Pt
Bld/Tiss
Nom
Molgen
MOLPATH.MUT
1
SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SETBP1 gene Mut Anl Bld/T
null
ACTIVE
2.72
2.72
100025-6
SRSF2 gene targeted mutation analysis
Prid
Pt
Bld/Tiss
Nom
Molgen
MOLPATH.MUT
1
SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SRSF2 gene Mut Anl Bld/T
null
ACTIVE
2.72
2.72
100026-4
MET gene targeted mutation analysis
Prid
Pt
Bld/Tiss
Nom
Molgen
MOLPATH.MUT
1
MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MET gene Mut Anl Bld/T
null
ACTIVE
2.72
2.72
100027-2
SMAD4 gene targeted mutation analysis
Prid
Pt
Bld/Tiss
Nom
Molgen
MOLPATH.MUT
1
SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SMAD4 gene Mut Anl Bld/T
null
ACTIVE
2.72
2.72
100028-0
FBXW7 gene targeted mutation analysis
Prid
Pt
Bld/Tiss
Nom
Molgen
MOLPATH.MUT
1
FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
FBXW7 gene Mut Anl Bld/T
null
ACTIVE
2.72
2.72
100029-8
Cancer related multigene analysis
Find
Pt
Plas.cfDNA
Doc
Molgen
MOLPATH
1
Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method
Cancer multigene analysis Plas.cfDNA
null
ACTIVE
2.72
2.72
100030-6
Axis I: Temporal aspects score
Score
Pt
^Patient
Qn
Mainz Pain Staging System
SURVEY.PAIN
4
Axis I: Temporal aspects score [Mainz Pain Staging System]
null
© 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission.
ACTIVE
2.72
2.72
100031-4
Axis II: Spatial aspects score
Score
Pt
^Patient
Qn
Mainz Pain Staging System
SURVEY.PAIN
4
Axis II: Spatial aspects score [Mainz Pain Staging System]
null
© 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission.
ACTIVE
2.72
2.72
10003-2
R wave duration.lead III
Time
Pt
Heart
Qn
EKG
EKG.MEAS
2
R wave duration in lead III
R wave dur L-III
null
ACTIVE
1.0i
2.48
100032-2
Axis III: Drug taking behavior score
Score
Pt
^Patient
Qn
Mainz Pain Staging System
SURVEY.PAIN
4
Axis III: Drug taking behavior score [Mainz Pain Staging System]
null
© 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission.
ACTIVE
2.72
2.72
100033-0
Axis IV: Utilization of the health care system score
Score
Pt
^Patient
Qn
Mainz Pain Staging System
SURVEY.PAIN
4
Axis IV: Utilization of the health care system score [Mainz Pain Staging System]
null
© 1999 H.U. Gerbershagen, J. Korb, B. Nagel, P. Nilges. Used with permission.
ACTIVE
2.72
2.72
100034-8
Provider of automated external defibrillator use
Type
Pt
^Patient
Nom
null
TRAUMA
2
Provider of automated external defibrillator use
Provider of AED
null
ACTIVE
2.72
2.72
100035-5
Exam finding location
Find
Pt
Chest
Nom
null
H&P.PX
2
Exam finding location of Chest
Exam finding location Chest
null
ACTIVE
2.72
2.72
100036-3
Exam finding location
Find
Pt
Lung
Nom
null
H&P.PX
2
Exam finding location of Lung
Exam finding location Lung
null
ACTIVE
2.72
2.72
100037-1
Patient contact disposition
Type
Pt
EMS unit
Nom
null
TRAUMA
2
Patient contact disposition EMS unit
Patient contact disposition EMS unit
null
ACTIVE
2.72
2.72
100038-9
Patient evaluation disposition
Type
Pt
EMS unit
Nom
null
TRAUMA
2
Patient evaluation disposition EMS unit
Patient eval disposition EMS unit
null
ACTIVE
2.72
2.72
100039-7
Crew disposition for patient care
Type
Pt
EMS unit
Nom
null
TRAUMA
2
Crew disposition for patient care EMS unit
Crew disposition EMS unit
null
ACTIVE
2.72
2.72
10004-0
R wave duration.lead V1
Time
Pt
Heart
Qn
EKG
EKG.MEAS
2
R wave duration in lead V1
R wave dur L-V1
null
ACTIVE
1.0i
2.48
100040-5
Patient transport disposition
Type
Pt
EMS unit
Nom
null
TRAUMA
2
Patient transport disposition EMS unit
Pt transport disposition EMS unit
null
ACTIVE
2.72
2.72
100041-3
Aminoglycoside
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Aminoglycoside [Susceptibility]
Aminoglycoside Susc Islt
null
ACTIVE
2.72
2.72
100042-1
Atovaquone
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Atovaquone [Susceptibility]
Atovaquone Susc Islt
null
ACTIVE
2.72
2.72
100043-9
Azithromycin+Ethambutol
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Azithromycin+Ethambutol [Susceptibility]
Azithro+Ethambut Susc Islt
null
ACTIVE
2.72
2.72
100044-7
Cefcapene
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Cefcapene [Susceptibility]
Cefcapene Susc Islt
null
ACTIVE
2.72
2.72
100045-4
Cefozopran
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Cefozopran [Susceptibility]
Cefozopran Susc Islt
null
ACTIVE
2.72
2.72
100046-2
Cefquinome
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Cefquinome [Susceptibility]
CEQ Susc Islt
null
ACTIVE
2.72
2.72
100047-0
Cefteram
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Cefteram [Susceptibility]
Cefteram Susc Islt
null
ACTIVE
2.72
2.72
100048-8
Clarithromycin+Ethambutol
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Clarithromycin+Ethambutol [Susceptibility]
Clarithro+Ethamb Susc Islt
null
ACTIVE
2.72
2.72
100049-6
Eravacycline
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Eravacycline [Susceptibility]
Eravacycline Susc Islt
null
ACTIVE
2.72
2.72
100050-4
Erythromycin+Ethambutol
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Erythromycin+Ethambutol [Susceptibility]
Erythro+Ethamb Susc Islt
null
ACTIVE
2.72
2.72
100051-2
Ethambutol+rifAMPin
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Ethambutol+rifAMPin [Susceptibility]
Ethambutol+rifAMPin Susc Islt
null
ACTIVE
2.72
2.72
100052-0
Flomoxef
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Flomoxef [Susceptibility]
Flomoxef Susc Islt
null
ACTIVE
2.72
2.72
100053-8
Fluoroquinolone
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Fluoroquinolone [Susceptibility]
FLQ Susc Islt
null
ACTIVE
2.72
2.72
100054-6
Gamithromycin
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Gamithromycin [Susceptibility]
Gamithromycin Susc Islt
null
ACTIVE
2.72
2.72
100055-3
Optochin
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Optochin [Susceptibility]
Optochin Susc Islt
null
ACTIVE
2.72
2.72
100056-1
Panipenem
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Panipenem [Susceptibility]
Panipenem Susc Islt
null
ACTIVE
2.72
2.72
10005-7
R wave duration.lead V2
Time
Pt
Heart
Qn
EKG
EKG.MEAS
2
R wave duration in lead V2
R wave dur L-V2
null
ACTIVE
1.0i
2.48
100057-9
Prothionamide
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Prothionamide [Susceptibility]
Prothionamide Susc Islt
null
ACTIVE
2.72
2.72
100058-7
Prulifloxacin
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Prulifloxacin [Susceptibility]
Prulifloxacin Susc Islt
null
ACTIVE
2.72
2.72
100059-5
Rifapentine
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Rifapentine [Susceptibility]
Rifapentine Susc Islt
null
ACTIVE
2.72
2.72
100060-3
Tildipirosin
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Tildipirosin [Susceptibility]
Tildipirosin Susc Islt
null
ACTIVE
2.72
2.72
100061-1
Tosufloxacin
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Tosufloxacin [Susceptibility]
Tosufloxacin Susc Islt
null
ACTIVE
2.72
2.72
100062-9
Standard Dermatology Outcome Measures panel
-
Pt
^Patient
-
SDOM
PANEL.CLIN
2
Standard Dermatology Outcome Measures panel
SDOM panel
Copyright © 2016 The Regents of the University of California and Emory University. Used with permission.
ACTIVE
2.72
2.72
100063-7
Primary skin concern
Find
Pt
^Patient
Nom
null
CLIN
2
Primary skin concern
Primary skin concern
null
ACTIVE
2.72
2.72
100064-5
Itch severity
Find
RptPeriod
^Patient
Ord
Reported
CLIN
2
Itch severity Reporting Period - Reported
Itch severity RptPeriod Reported
null
ACTIVE
2.72
2.72
10006-5
R wave duration.lead V3
Time
Pt
Heart
Qn
EKG
EKG.MEAS
2
R wave duration in lead V3
R wave dur L-V3
null
ACTIVE
1.0i
2.48
100065-2
Satisfied with treatment
Find
Pt
^Patient
Ord
null
CLIN
2
Satisfied with treatment
Satisfied with treatment
null
ACTIVE
2.72
2.72
100066-0
Specular microscopy panel
-
Pt
Eye
-
Specular microscopy
PANEL.EYE
2
Specular microscopy panel
Specular microscopy panel
null
TRIAL
2.72
2.72
100067-8
Image magnification
Len
Pt
Eye
Qn
null
EYE.SPECULAR MICROSCOPY
2
Eye Image magnification
Eye Image magnification
null
TRIAL
2.72
2.72
100068-6
Fixation point
Angle
Pt
Eye.right
Nom
null
EYE.SPECULAR MICROSCOPY
2
Right eye Fixation point [Angle]
R eye Fixation point [Angle]
null
TRIAL
2.72
2.72
100069-4
Fixation point
Angle
Pt
Eye.left
Nom
null
EYE.SPECULAR MICROSCOPY
2
Left eye Fixation point [Angle]
L eye Fixation point [Angle]
null
TRIAL
2.72
2.72
100070-2
Cell density
Naric
Pt
Cornea.right
Qn
null
EYE.SPECULAR MICROSCOPY
2
Right cornea Cell density
R cornea Cell density
null
TRIAL
2.72
2.72
100071-0
Cell density
Naric
Pt
Cornea.left
Qn
null
EYE.SPECULAR MICROSCOPY
2
Left cornea Cell density
L cornea Cell density
null
TRIAL
2.72
2.72
100072-8
Coefficient of variation
ArLen
Pt
Cornea.right
Qn
null
EYE.SPECULAR MICROSCOPY
2
Right cornea Coefficient of variation
R cornea Coefficient of variation
null
TRIAL
2.72
2.72
10007-3
R wave duration.lead V4
Time
Pt
Heart
Qn
EKG
EKG.MEAS
2
R wave duration in lead V4
R wave dur L-V4
null
ACTIVE
1.0i
2.48
100073-6
Coefficient of variation
ArLen
Pt
Cornea.left
Qn
null
EYE.SPECULAR MICROSCOPY
2
Left cornea Coefficient of variation
L cornea Coefficient of variation
null
TRIAL
2.72
2.72
100074-4
Hexagonality
RelRto
Pt
Cornea.right
Qn
null
EYE.SPECULAR MICROSCOPY
2
Right cornea Hexagonality
R cornea Hexagonality
null
TRIAL
2.72
2.72
100075-1
Hexagonality
RelRto
Pt
Cornea.left
Qn
null
EYE.SPECULAR MICROSCOPY
2
Left cornea Hexagonality
L cornea Hexagonality
null
TRIAL
2.72
2.72
100076-9
Endothelial cells counted
Num
Pt
Cornea.right
Qn
null
EYE.SPECULAR MICROSCOPY
2
Right cornea Endothelial cells counted
R cornea Endothelial cells counted
null
TRIAL
2.72
2.72
100077-7
Endothelial cells counted
Num
Pt
Cornea.left
Qn
null
EYE.SPECULAR MICROSCOPY
2
Left cornea Endothelial cells counted
L cornea Endothelial cells counted
null
TRIAL
2.72
2.72
100078-5
Endothelial cell area.min
Area
Pt
Cornea.right
Qn
null
EYE.SPECULAR MICROSCOPY
2
Right cornea Endothelial cell area.min
R cornea Endothelial cell area.min
null
TRIAL
2.72
2.72
100079-3
Endothelial cell area.min
Area
Pt
Cornea.left
Qn
null
EYE.SPECULAR MICROSCOPY
2
Left cornea Endothelial cell area.min
L cornea Endothelial cell area.min
null
TRIAL
2.72
2.72
100080-1
Endothelial cell area.max
Area
Pt
Cornea.right
Qn
null
EYE.SPECULAR MICROSCOPY
2
Right cornea Endothelial cell area.max
R cornea Endothelial cell area.max
null
TRIAL
2.72
2.72
10008-1
R wave duration.lead V5
Time
Pt
Heart
Qn
EKG
EKG.MEAS
2
R wave duration in lead V5
R wave dur L-V5
null
ACTIVE
1.0i
2.48
100081-9
Endothelial cell area.max
Area
Pt
Cornea.left
Qn
null
EYE.SPECULAR MICROSCOPY
2
Left cornea Endothelial cell area.max
L cornea Endothelial cell area.max
null
TRIAL
2.72
2.72
100082-7
Endothelial cell area.mean
Area
Pt
Cornea.right
Qn
null
EYE.SPECULAR MICROSCOPY
2
Right cornea Endothelial cell area.mean
R cornea Endothelial cell area.mean
null
TRIAL
2.72
2.72
100083-5
Endothelial cell area.mean
Area
Pt
Cornea.left
Qn
null
EYE.SPECULAR MICROSCOPY
2
Left cornea Endothelial cell area.mean
L cornea Endothelial cell area.mean
null
TRIAL
2.72
2.72
100084-3
Cell area.standard deviation
Area
Pt
Cornea.right
Qn
null
EYE.SPECULAR MICROSCOPY
2
Right cornea Cell area.standard deviation
R cornea Cell area.sd
null
TRIAL
2.72
2.72
100085-0
Cell area.standard deviation
Area
Pt
Cornea.left
Qn
null
EYE.SPECULAR MICROSCOPY
2
Left cornea Cell area.standard deviation
L cornea Cell area.sd
null
TRIAL
2.72
2.72
100086-8
Analysis method
Type
Pt
Cornea.right
Nom
Specular microscopy
EYE.SPECULAR MICROSCOPY
2
Right cornea Type of Analysis method by Specular microscopy
R cornea Analysis method
null
TRIAL
2.72
2.72
100087-6
Toxocara canis 24-35kD Ab.IgG
PrThr
Pt
Ser
Ord
IB
MICRO
1
Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot
T canis 24-35kD IgG Ser Ql IB
null
ACTIVE
2.72
2.72
100088-4
Taenia solium larva Ab bands panel
-
Pt
Ser
-
IB
PANEL.MICRO
1
Taenia solium larva Ab bands panel - Serum by Immunoblot
T solium Ab bands Pnl Ser IB
null
ACTIVE
2.72
2.72
100089-2
Taenia solium larva 6-8kD Ab
PrThr
Pt
Ser
Ord
IB
MICRO
1
Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot
T solium 6-8kD Ab Ser Ql IB
null
ACTIVE
2.72
2.72
1000-9
DBG Ab
PrThr
Pt
Ser/Plas^BPU
Ord
null
BLDBK
1
DBG Ab [Presence] in Serum or Plasma from Blood product unit
DBG Ab SerPl BPU Ql
null
ACTIVE
1.0
2.56
100090-0
Taenia solium larva 45kD Ab
PrThr
Pt
Ser
Ord
IB
MICRO
1
Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot
T solium 45kD Ab Ser Ql IB
null
ACTIVE
2.72
2.72
100091-8
Trypanosoma cruzi Ab
ACnc
Pt
Ser
Qn
IA
MICRO
1
Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay
T cruzi Ab Ser IA-aCnc
null
ACTIVE
2.72
2.72